What patient types or clinical scenarios--sex of patient, aggressiveness of disease, poor treatment response, host risk factors, history of response, etc.--are ideally aligned with agents targeting IL-6?

What patient types or clinical scenarios--sex of patient, aggressiveness of disease, poor treatment response, host risk factors, history of response, etc.--are ideally aligned with agents targeting IL-6?

What patient types or clinical scenarios—sex of patient, aggressiveness of disease, poor treatment response, host risk factors, history of response, etc.—are ideally aligned with agents targeting IL-6?

CLICK HERE FOR CME CREDIT

Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Eric Ruderman, MD

Eric Ruderman, MD

Professor of Medicine
Division of Rheumatology
Northwestern University, Feinberg School of Medicine
Chicago, Illinois